Long-read sequencing pure-play. HiFi (Revio, Vega desktop) answers a different question than Illumina (structural variants, full-length isoforms). BIOSECURE tailwind.
Research snapshot · Not reviewed
PACBPacific Biosciences
HiFi long-read sequencing
Open PACB in Robinhood ↗Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap$522MSnapshot value
Vega desktop launch expanding addressable market; PureTarget for hard-to-call clinical regions; BIOSECURE reshoring; long-read clinical adoption (rare disease, oncology).
Unprofitable (~$522M market cap, negative EBITDA); Illumina + Roche squeezing from both sides; ONT competition in native long-read; slow clinical reimbursement pathway.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟢 Lean-Bull · ins-$1.4M · 13F 11+/13- · short↓0.18
Snapshot · Not reviewed